The purpose of the study is to describe the psychometric properties (validity, reliability and responsiveness) of the SQOL-6D instrument in the context of routine clinical treatment of upper limb spasticity.
The purpose of the study is to describe the psychometric properties (validity, reliability and responsiveness) of the SQOL-6D instrument in the context of routine clinical treatment of upper limb spasticity.
The purpose of this study is to assess the safety and efficacy of increasing doses of IPN10200, with the aim to establish the doses(s) that offer the best efficacy/safety profile when used for the treatment of AUL spasticity. Study details include: Study Participant Duration: The total double-blind study duration for a participant will be up